Phase II study: gemcitabine plus epirubicin in malignant pleural mesothelioma. An A.I.P.O. Chest Oncology Study Group trial.
- Resource Type
- Academic Journal
- Source
- Annals of Oncology. Jan 01, 2000 11 Suppl 4:111-111
- Subject
- Language
- English
- ISSN
- 0923-7534